Graumann et al.[152], investigating gene expression in the NAWM of patients with secondary progressive MS and healthy controls, showed that the patients with MS exhibited consistent differences in the expression of hypoxia-inducible factor (HIF)-1a compared with controls. Here, HIF1A is linked to myeloid sarcoma.